Category Archives: Midd Blogosphere

Summer 2022 at Spurrier Capital Partners

Nicky Johnson ’22 wrote recently to share that Spurrier Capital Partners has launched their Summer 2022 Investment Banking recruiting cycle. Spurrier Capital Partners (SCP) is an elite boutique investment bank, based in New York City, specializing in M&A advisory and Private Placements in the Enterprise Technology space. The firm was named the Technology Investment Bank of the Year in 2020 by the Global M&A Network. For more information about the firm, visit or check out the PDF attached.

TO APPLY: Rising Juniors, please fill out the Handshake Application.

The deadline is July 16, 2021 at midnight, but I’d recommend sending this in as soon as possible as the recruiting process has already started!

If you have questions about the firm or the recruiting process, feel free to reach out to Nicky or alumna Victoria Villalba, who is an Analyst at SCP. Have a great rest of the summer!

Post-Grad STEM Fellowship Opportunity: Churchill Scholarship at Cambridge

Are you a senior STEM student interested in pursuing a Master’s Degree? Do you like the idea of studying at one of the oldest universities in the world?

Consider the Churchill Scholarship, which provides funding to American students for a year of Master’s study at the University of Cambridge. The program was set up at the request of Winston Churchill to fulfill his vision of a transatlantic scientific exchange with the goal of advancing science and technology.

The application for 16 Churchill Scholarships in science, mathematics, and engineering is now open. The nomination deadline is Monday, November 1, 2021 (5pm Eastern Time) for matriculation in the 2022-23 academic year.

Article: Fight Over Covid’s Origins Renews Debate on Risks of Lab Work

By Carl Zimmer and James Gorman, June 20, 2021

At a Senate hearing on efforts to combat Covid-19 last month, Senator Rand Paul of Kentucky asked Dr. Anthony S. Fauci whether the National Institutes of Health had funded “gain-of-function” research on coronaviruses in China.

“Gain-of-function research, as you know, is juicing up naturally occurring animal viruses to infect humans,” the senator said.

Dr. Fauci, the nation’s top infectious disease expert, flatly rejected the claim: “Senator Paul, with all due respect, you are entirely and completely incorrect, that the N.I.H. has not ever and does not now fund gain-of-function research in the Wuhan Institute.”

This exchange, and the bit of scientific jargon at the heart of it, has gained traction in recent weeks, usually by people suggesting that the coronavirus was engineered, rather than having jumped from animals to humans, the explanation favored by most experts on coronaviruses. The uproar has also drawn attention back to a decade-long debate among scientists over whether certain gain-of-function research is too risky to allow.

Spurred by some contested bird flu experiments in 2012, the U.S. government adjusted its policies for oversight of certain types of pathogen studies. But some critics in the scientific community say that the policy is overly restrictive and that its enforcement has been far from transparent.

The stakes of the debate could not be higher. Too little research on emerging viruses will leave us unprepared for future pandemics. But too little attention to the safety risks will increase the chances that an experimental pathogen may escape a lab through an accident and cause an outbreak of its own.

Sorting out the balance of risks and benefits of the research has proved over the years to be immensely challenging. And now, the intensity of the politics and rhetoric over the lab leak theory threatens to push detailed science policy discussions to the sidelines.

“It’s just going to make it harder to get back to a serious debate,” said Marc Lipsitch, an epidemiologist at the Harvard T.H. Chan School of Public Health who has urged the government to be more transparent about its support of gain-of-function research.

June Notes for Watson and Fulbright Applicants

If you’re thinking about applying for a Fulbright or Watson nomination in the fall, you should start working on those applications. Many of you have already talked with me about your ideas or completed a preliminary application this spring. But yes, you can still apply for these in the fall even if you did not […]